Alembic Pharmaceuticals has informed that the exchange has sought clarification from Alembic Pharmaceuticals with respect to news article appearing on www.financialexpress.com May 25, 2021 titled ‘Alembic gets Gujarat FDCA licence for anti-black fungal drug Amphotericin-B’.
The above information is a part of company’s filings submitted to BSE.